Genetic engineering with T cell receptorsLING ZHANG; MORGAN, Richard A.Advanced drug delivery reviews. 2012, Vol 64, Num 8, pp 756-762, issn 0169-409X, 7 p.Article

Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNAMAUTINO, Mario R; MORGAN, Richard A.Human gene therapy. 2000, Vol 11, Num 14, pp 2025-2037, issn 1043-0342Article

Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNAMAUTINO, Mario R; MORGAN, Richard A.Human gene therapy. 2002, Vol 13, Num 9, pp 1027-1037, issn 1043-0342Article

Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy TrialsDAVIS, Jeremy L; THEORET, Marc R; ZHILI ZHENG et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5852-5861, issn 1078-0432, 10 p.Article

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD 19KOCHENDERFER, James N; WILSON, Wyndham H; MORGAN, Richard A et al.Blood. 2010, Vol 116, Num 20, pp 4099-4102, issn 0006-4971, 4 p.Article

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenJOHNSON, Laura A; MORGAN, Richard A; LEE, Chyi-Chia R et al.Blood. 2009, Vol 114, Num 3, pp 535-546, issn 0006-4971, 12 p.Article

Selecting highly affine and well-expressed TCRs for gene therapy of melanomaJORRITSMA, Annelies; GOMEZ-EERLAND, Raquel; HAANEN, John B. A. G et al.Blood. 2007, Vol 110, Num 10, pp 3564-3572, issn 0006-4971, 9 p.Article

Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expressionLIZEE, Gregory; AERTS, Joeri L; GONZALES, Monica I et al.Human gene therapy. 2003, Vol 14, Num 6, pp 497-507, issn 1043-0342, 11 p.Article

Toxicity of a first-generation adenoviral vector in rhesus macaquesLOZIER, Jay N; CSAKO, Gyorgy; MONDORO, Traci H et al.Human gene therapy. 2002, Vol 13, Num 1, pp 113-124, issn 1043-0342Article

EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen LossSAMPSON, John H; CHOI, Bryan D; HERNDON, James E et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 972-984, issn 1078-0432, 13 p.Article

Human effector CD8⁺ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyHINRICHS, Christian S; BORMAN, Zachary A; MURANSKI, Pawel et al.Blood. 2011, Vol 117, Num 3, pp 808-814, issn 0006-4971, 7 p.Article

A Simplified Method for the Clinical-scale Generation of Central Memory-like CD8+ T Cells After Transduction With Lentiviral Vectors Encoding Antitumor Antigen T-cell ReceptorsSHICHENG YANG; DUDLEY, Mark E; ROSENBERG, Steven A et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 6, pp 648-658, issn 1524-9557, 11 p.Article

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorKOCHENDERFER, James N; FELDMAN, Steven A; YANGBING ZHAO et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 7, pp 689-702, issn 1524-9557, 14 p.Article

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stabilityCOHEN, Cyrille J; YANGBING ZHAO; ZHILI ZHENG et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8878-8886, issn 0008-5472, 9 p.Article

High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytesROSSI, Gabriela R; MAUTINO, Mario R; MORGAN, Richard A et al.Human gene therapy. 2003, Vol 14, Num 4, pp 385-391, issn 1043-0342, 7 p.Article

Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in MiceCHINNASAMY, Dhanalakshmi; TRAN, Eric; ZHIYA YU et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 11, pp 3371-3380, issn 0008-5472, 10 p.Article

Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in MiceCHINNASAMY, Dhanalakshmi; ZHIYA YU; KERKAR, Sid P et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1672-1683, issn 1078-0432, 12 p.Article

Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term SurvivorsYACHIDA, Shinichi; WHITE, Catherine M; HRUBAN, Ralph H et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6339-6347, issn 1078-0432, 9 p.Article

Lentiviral Vector Design for Optimal T Cell Receptor Gene Expression in the Transduction of Peripheral Blood Lymphocytes and Tumor-Infiltrating LymphocytesJONES, Stephanie; PENG, Peter D; SHICHENG YANG et al.Human gene therapy. 2009, Vol 20, Num 6, pp 630-640, issn 1043-0342, 11 p.Article

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expressionWARGO, Jennifer A; ROBBINS, Paul F; ROSENBERG, Steven A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 3, pp 383-394, issn 0340-7004, 12 p.Article

Cytokine-independent growth and clonal expansion of a primary human CD8⁺ T-cell clone following retroviral transduction with the IL-15 geneHSU, Cary; JONES, Stephanie A; DUNBAR, Cynthia E et al.Blood. 2007, Vol 109, Num 12, pp 5168-5177, issn 0006-4971, 10 p.Article

Genetic Engineering of Murine CD8⁺ and CD4⁺ T Cells for Preclinical Adoptive Immunotherapy StudiesKERKAR, Sid P; SANCHEZ-PEREZ, Luis; SCOTT, Christopher D et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 343-352, issn 1524-9557, 10 p.Article

Tumor-Specific CD8⁺ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsKERKAR, Sid P; MURANSKI, Pawel; MORGAN, Richard A et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6725-6734, issn 0008-5472, 10 p.Article

Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2HEEMSKERK, Bianca; KE LIU; MORGAN, Richard A et al.Human gene therapy. 2008, Vol 19, Num 5, pp 496-510, issn 1043-0342, 15 p.Article

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCOHEN, Cyrille J; LI, Yong F; EL-GAMIL, Mona et al.Cancer research (Baltimore). 2007, Vol 67, Num 8, pp 3898-3903, issn 0008-5472, 6 p.Article